{"disease":{"id":"metastatic-liver-cancer","name":"metastatic liver cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04513457","title":"Chemotherapy for Resectable Colorectal Liver Metastases","phase":"","overall_status":"COMPLETED","enrollment_count":967,"lead_sponsor_name":"Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","has_results":false},{"nct_id":"NCT06342427","title":"Stomach Cancer Exosome-based Detection","phase":"","overall_status":"COMPLETED","enrollment_count":809,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT05038254","title":"Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":750,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05714124","title":"Liver Embolization Approaches for Tumor Management","phase":"","overall_status":"RECRUITING","enrollment_count":580,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT05863195","title":"Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":408,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":false},{"nct_id":"NCT04907643","title":"Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes","phase":"NA","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT01010126","title":"Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":252,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT02364557","title":"Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"NRG Oncology","has_results":true},{"nct_id":"NCT04708483","title":"DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Hyperfusion","has_results":false},{"nct_id":"NCT04046445","title":"Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":96,"lead_sponsor_name":"Amal Therapeutics","has_results":false},{"nct_id":"NCT07410494","title":"Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":85,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT03823144","title":"Intravital Microscopy in Human Solid Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":85,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07410676","title":"EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":83,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT06440005","title":"A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Angiex, Inc.","has_results":false},{"nct_id":"NCT00862680","title":"4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis","phase":"","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06905015","title":"Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection","phase":"NA","overall_status":"RECRUITING","enrollment_count":74,"lead_sponsor_name":"Warangkana Lapisatepun","has_results":false},{"nct_id":"NCT04796818","title":"An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04081168","title":"COLLISION XL: Unresectable Colorectal Liver Metastases (3-5cm): Stereotactic Body Radiotherapy vs. Microwave Ablation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":68,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT04970212","title":"Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures","phase":"","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Techsomed Medical Technologies LTD","has_results":false},{"nct_id":"NCT07043387","title":"Streamlining Radioembolization for CCC and Metastatic Liver Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT07341737","title":"SL-28 for Advanced Solid Tumours","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Second Life Therapeutics","has_results":false},{"nct_id":"NCT07260058","title":"Immune Cell Therapy for Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.","has_results":false},{"nct_id":"NCT07500220","title":"Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Beijing Biotech","has_results":false},{"nct_id":"NCT02738606","title":"Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":29,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT02754856","title":"Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT02809716","title":"High Definition Single Cell Analysis in Colorectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT04864054","title":"T-Cell Therapy (ECT204) in Adults With Advanced HCC","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Eureka Therapeutics Inc.","has_results":false},{"nct_id":"NCT03403634","title":"Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT05240950","title":"Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT06533332","title":"A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"EtiraRx Australia Pty Ltd","has_results":false},{"nct_id":"NCT04634357","title":"ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Eureka Therapeutics Inc.","has_results":false},{"nct_id":"NCT07312292","title":"Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Niek Wijnen","has_results":false},{"nct_id":"NCT06689540","title":"Mts105 for Advanced Hepatocellular Carcinoma","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":14,"lead_sponsor_name":"Shen Lin","has_results":false},{"nct_id":"NCT04785287","title":"Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03888859","title":"ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT03028311","title":"Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04973007","title":"Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT03373188","title":"VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT06852820","title":"68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Melissa Lumish","has_results":false},{"nct_id":"NCT05375604","title":"A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Codiak BioSciences","has_results":false},{"nct_id":"NCT03005002","title":"Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT04926376","title":"Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)","phase":"NA","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"ABK Biomedical","has_results":false},{"nct_id":"NCT04502082","title":"Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Eureka Therapeutics Inc.","has_results":false},{"nct_id":"NCT06173726","title":"Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":6,"lead_sponsor_name":"BioSyngen Pte Ltd","has_results":false},{"nct_id":"NCT03844750","title":"Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Chloe Atreya, MD, PhD","has_results":true},{"nct_id":"NCT04108481","title":"Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"University of Iowa","has_results":false},{"nct_id":"NCT05582018","title":"Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures","phase":"NA","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Techsomed Medical Technologies LTD","has_results":false},{"nct_id":"NCT03993327","title":"An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT03349255","title":"Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Aeon Therapeutics (Shanghai) Co., Ltd.","has_results":false},{"nct_id":"NCT03998033","title":"Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Eureka Therapeutics Inc.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}